How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

XE

OOTC:XENO
Get a brief AI stock analysisSaves ~ 15 minutes of your time

XE

Xeno Transplants CorpOOTC XENO Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

OOTC - OTC

FAIR VALUE

Is XENO undervalued compared to its fair value?

The fair value of XENO stock is hidden USD. Relative to the market price of 0 USD Xeno Transplants Corp is hidden.

Xeno Transplants Corporation, formerly Icon Development, Inc., is a bio-technology research and development company that holds an exclusive commercial license from Massachusetts General Hospital derived from over 15 year...[More about valuation]

Xeno Transplants Corp Fair Value

hidden
UNLOCK
What is fair value?

Market cap:

Price:

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

STOCK ANALYSIS

Is XENO attractive for investment based on fundamental analysis?

XENO stock rating is hidden. Xeno Transplants Corp is a hidden by Eyestock methodology.

Get XENO Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

Gross Margin:

CFO / Debt ratio:

hidden

Current ratio:

Debt / Equity ratio:

ROE:

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

XENO analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for XENO to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

Xeno Transplants Corp competitors

AB

ABBV

Abbvie Inc

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. The company is headquartered in North Chicago, Ill...

Discover

AM

AMGN

Amgen Inc

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. The Company...

Discover

VR

VRTX

Vertex Pharmaceuticals Inc

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs fo...

Discover

Xeno Transplants Corp dividends

XENO dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About XENO stock

About the company Xeno Transplants Corp

Market cap $B

Dividend yield

Shares outstanding

40.36 B

Website

Xeno Transplants Corporation, formerly Icon Development, Inc., is a bio-technology research and development company that holds an exclusive commercial license from Massachusetts General Hospital derived from over 15 years of development in the field of xenotransplantation by Novartis Pharmaceuticals and its associated research entities. The Company intends to develop therapeutic applications of organs and cells derived from genetically engineered pigs as a transplant alternative to limited human donor sources.

XENO profile

  • Ticker

    XENO

  • Country

    Canada

  • Exchange

    OOTC - OTC

  • Report currency

    USD - US dollar

  • IPO date

    01 August 2006

  • Sector

    Healthсare

  • Industry

    Biotechnology

  • Employees

  • City

    Vancouver

  • Address

    1066 Hastings St W Suite 2610

  • Cusip

    98410N107